Seroprevalence of COVID-19 in Blood Donors: A Systematic Review and Meta-Analysis
Introduction. Determining the prevalence of SARS-CoV-2 in blood donors makes the control of virus circulation possible in healthy people and helps implement strategies to reduce virus transmission. The purpose of the study was to examine the seroprevalence of COVID-19 in blood donors using systemati...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Advances in Virology |
| Online Access: | http://dx.doi.org/10.1155/2022/9342680 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832551212941049856 |
|---|---|
| author | Hassan Nourmohammadi Ali Hasanpour Dehkordi Amir Adibi Seyed Mohammad Amin Hashemipour Mohsen Abdan Moloud Fakhri Zahra Abdan Diana Sarokhani |
| author_facet | Hassan Nourmohammadi Ali Hasanpour Dehkordi Amir Adibi Seyed Mohammad Amin Hashemipour Mohsen Abdan Moloud Fakhri Zahra Abdan Diana Sarokhani |
| author_sort | Hassan Nourmohammadi |
| collection | DOAJ |
| description | Introduction. Determining the prevalence of SARS-CoV-2 in blood donors makes the control of virus circulation possible in healthy people and helps implement strategies to reduce virus transmission. The purpose of the study was to examine the seroprevalence of COVID-19 in blood donors using systematic review and meta-analysis. Materials and Methods. The electronic databases PubMed, Scopus, Web of Science, and the Google Scholar search engine were searched using standard keywords up to 2022-04-26. The variance of each study was calculated according to the binomial distribution. Studies were combined according to the sample size and variance. Q Cochrane test and I2 index were used to examine the heterogeneity of the studies. Data analysis was performed in STATA 14 software, and the significance level of the tests was P<0.05. Results. In the 28 papers examined with 227894 samples, the seroprevalence of COVID-19 in blood donors was 10% (95% CI: 9%, 11%), estimated 5% (95% CI: 4%, 7%) among men and 6% (95% CI: 4%, 7%) among women. This rate in different blood groups was as follows: A 12% (95% CI: 10%–14%), B 12% (95% CI: 10%–15%), AB 9% (95% CI: 7%–12%), and O 13% (95% CI: 11%–16%). The seroprevalence of COVID-19 in blood donors in North America 10%, Europe 7%, Asia 23%, South America 5%, and Africa was 4%; Moreover, the seroprevalence of IgG antibodies was estimated to be 23% (95% CI: 18%–29%) and IgM 29% (95% CI: 9%–49%). Conclusion. The highest prevalence of COVID-19 serum in women blood donors was among blood group O and Asia. The seroprevalence of IgG and IgM antibodies was high too. |
| format | Article |
| id | doaj-art-c23b5421c61b40aea5c0d937486d7b51 |
| institution | Kabale University |
| issn | 1687-8647 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Advances in Virology |
| spelling | doaj-art-c23b5421c61b40aea5c0d937486d7b512025-02-03T06:04:45ZengWileyAdvances in Virology1687-86472022-01-01202210.1155/2022/9342680Seroprevalence of COVID-19 in Blood Donors: A Systematic Review and Meta-AnalysisHassan Nourmohammadi0Ali Hasanpour Dehkordi1Amir Adibi2Seyed Mohammad Amin Hashemipour3Mohsen Abdan4Moloud Fakhri5Zahra Abdan6Diana Sarokhani7Department of Internal MedicineSocial Determinants of Health Research CenterDepartment of Child and Adolescent PsychiatryYoung Researchers and Elites ClubResearch Center for Environmental Determinants of HealthTraditional and Complementary Medicine Research CenterClinical Research Development CenterResearch Center for Environmental Determinants of HealthIntroduction. Determining the prevalence of SARS-CoV-2 in blood donors makes the control of virus circulation possible in healthy people and helps implement strategies to reduce virus transmission. The purpose of the study was to examine the seroprevalence of COVID-19 in blood donors using systematic review and meta-analysis. Materials and Methods. The electronic databases PubMed, Scopus, Web of Science, and the Google Scholar search engine were searched using standard keywords up to 2022-04-26. The variance of each study was calculated according to the binomial distribution. Studies were combined according to the sample size and variance. Q Cochrane test and I2 index were used to examine the heterogeneity of the studies. Data analysis was performed in STATA 14 software, and the significance level of the tests was P<0.05. Results. In the 28 papers examined with 227894 samples, the seroprevalence of COVID-19 in blood donors was 10% (95% CI: 9%, 11%), estimated 5% (95% CI: 4%, 7%) among men and 6% (95% CI: 4%, 7%) among women. This rate in different blood groups was as follows: A 12% (95% CI: 10%–14%), B 12% (95% CI: 10%–15%), AB 9% (95% CI: 7%–12%), and O 13% (95% CI: 11%–16%). The seroprevalence of COVID-19 in blood donors in North America 10%, Europe 7%, Asia 23%, South America 5%, and Africa was 4%; Moreover, the seroprevalence of IgG antibodies was estimated to be 23% (95% CI: 18%–29%) and IgM 29% (95% CI: 9%–49%). Conclusion. The highest prevalence of COVID-19 serum in women blood donors was among blood group O and Asia. The seroprevalence of IgG and IgM antibodies was high too.http://dx.doi.org/10.1155/2022/9342680 |
| spellingShingle | Hassan Nourmohammadi Ali Hasanpour Dehkordi Amir Adibi Seyed Mohammad Amin Hashemipour Mohsen Abdan Moloud Fakhri Zahra Abdan Diana Sarokhani Seroprevalence of COVID-19 in Blood Donors: A Systematic Review and Meta-Analysis Advances in Virology |
| title | Seroprevalence of COVID-19 in Blood Donors: A Systematic Review and Meta-Analysis |
| title_full | Seroprevalence of COVID-19 in Blood Donors: A Systematic Review and Meta-Analysis |
| title_fullStr | Seroprevalence of COVID-19 in Blood Donors: A Systematic Review and Meta-Analysis |
| title_full_unstemmed | Seroprevalence of COVID-19 in Blood Donors: A Systematic Review and Meta-Analysis |
| title_short | Seroprevalence of COVID-19 in Blood Donors: A Systematic Review and Meta-Analysis |
| title_sort | seroprevalence of covid 19 in blood donors a systematic review and meta analysis |
| url | http://dx.doi.org/10.1155/2022/9342680 |
| work_keys_str_mv | AT hassannourmohammadi seroprevalenceofcovid19inblooddonorsasystematicreviewandmetaanalysis AT alihasanpourdehkordi seroprevalenceofcovid19inblooddonorsasystematicreviewandmetaanalysis AT amiradibi seroprevalenceofcovid19inblooddonorsasystematicreviewandmetaanalysis AT seyedmohammadaminhashemipour seroprevalenceofcovid19inblooddonorsasystematicreviewandmetaanalysis AT mohsenabdan seroprevalenceofcovid19inblooddonorsasystematicreviewandmetaanalysis AT moloudfakhri seroprevalenceofcovid19inblooddonorsasystematicreviewandmetaanalysis AT zahraabdan seroprevalenceofcovid19inblooddonorsasystematicreviewandmetaanalysis AT dianasarokhani seroprevalenceofcovid19inblooddonorsasystematicreviewandmetaanalysis |